Revision of Previously Issued Financial Statements for Correction of Immaterial Errors (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Revision of Previously Issued Financial Statements for Correction of Immaterial Errors |
|
| Schedule of condensed balance sheet |
December 31, 2025 | | As Previously Reported | | | Adjustment | | | As Restated | | Accounts payable and accrued expenses | | $ | 1,052,255 | | | $ | 108,521 | | | $ | 1,160,776 | | Total current liabilities | | | 3,943,149 | | | | 108,521 | | | | 4,051,670 | | Total liabilities | | | 4,193,149 | | | | 108,521 | | | | 4,301,670 | | Accumulated deficit | | | (81,370,291 | ) | | | (108,521 | ) | | | (81,478,812 | ) | Total stockholders’ deficit | | | (3,876,451 | ) | | | (108,521 | ) | | | (3,984,972 | ) | Total liabilities and stockholders’ deficit | | $ | 316,698 | | | $ | - | | | $ | 316,698 | |
|
| Schedule of condensed statement of operations |
Six Months Ended June 30, 2025 | | As Previously Reported | | | Adjustment | | | As Restated | | Research and development | | $ | 197,234 | | | $ | 7,470 | | | $ | 204,704 | | Total operating expenses | | | 1,757,572 | | | | 7,470 | | | | 1,765,042 | | Loss from operations | | | (1,757,572 | ) | | | (7,470 | ) | | | (1,765,042 | ) | Net loss | | | (1,846,846 | ) | | | (7,470 | ) | | | (1,854,316 | ) | Basic and diluted net loss per common share | | $ | (0.01 | ) | | $ | - | | | $ | (0.01 | ) |
|
| Schedule of condensed statement of stockholders' deficiency |
2025 Comparative Period | | As Previously Reported | | | Adjustment | | | As Restated | | Accumulated deficit at December 31, 2024 | | $ | (78,700,943 | ) | | $ | (14,915 | ) | | $ | (78,715,858 | ) | Total stockholders’ deficit at December 31, 2024 | | | (2,443,831 | ) | | | (14,915 | ) | | | (2,458,746 | ) | Net loss for the three months ended March 31, 2025 | | | (1,531,659 | ) | | | (7,470 | ) | | | (1,539,129 | ) | Accumulated deficit at March 31, 2025 | | | (80,232,602 | ) | | | (22,385 | ) | | | (80,254,987 | ) | Total stockholders’ deficit at March 31, 2025 | | | (2,855,365 | ) | | | (22,385 | ) | | | (2,877,750 | ) | Net loss for the three months ended June 30, 2025 | | | (315,187 | ) | | | — | | | | (315,187 | ) | Accumulated deficit at June 30, 2025 | | | (80,547,789 | ) | | | (22,385 | ) | | | (80,570,174 | ) | Total stockholders’ deficit at June 30, 2025 | | $ | (3,170,552 | ) | | $ | (22,385 | ) | | $ | (3,192,937 | ) |
|
| Schedule of condensed statement of cash flow |
Six Months Ended June 30, 2025 | | As Previously Reported | | | Adjustment | | | As Restated | | Net loss | | $ | (1,846,846 | ) | | $ | (7,470 | ) | | $ | (1,854,316 | ) | Increase in accounts payable and accrued expenses | | | 125,534 | | | | 7,470 | | | | 133,004 | | Net cash used in operating activities | | $ | (458,658 | ) | | $ | — | | | $ | (458,658 | ) |
|